Cargando…

Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial

Detalles Bibliográficos
Autores principales:	Facchinetti, Francesco, Tiseo, Marcello, Bertolaccini, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743524/ https://www.ncbi.nlm.nih.gov/pubmed/35070743 http://dx.doi.org/10.21037/tlcr-21-882

Ejemplares similares

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
por: Qiu, Bin, et al.
Publicado: (2021)

Expert consensus on perioperative treatment for non-small cell lung cancer
por: Duan, Jianchun, et al.
Publicado: (2022)

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis
por: Facchinetti, Francesco, et al.
Publicado: (2021)

Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
por: Liang, Wenhua, et al.
Publicado: (2020)

Anti-angiogenesis boosts chemo-immunotherapy in patients with EGFR mutations or baseline liver metastases: insights from IMpower150 study
por: Rebuzzi, Sara Elena, et al.
Publicado: (2019)

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
por: Facchinetti, Francesco, et al.
Publicado: (2018)

Non-small-cell lung cancer: how to manage BRAF-mutated disease
por: Guaitoli, Giorgia, et al.
Publicado: (2023)

International expert consensus on immunotherapy for early-stage non-small cell lung cancer
por: Liang, Wenhua, et al.
Publicado: (2022)

Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?
por: Bertolaccini, Luca, et al.
Publicado: (2023)

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis
por: Guaitoli, Giorgia, et al.
Publicado: (2021)

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials
por: Facchinetti, Francesco, et al.
Publicado: (2020)

Cystic brain metastases and RET fusion in lung cancer
por: Remon, Jordi, et al.
Publicado: (2020)

The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
por: Mohamed, Shehab, et al.
Publicado: (2023)

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
por: Rossi, Giulio, et al.
Publicado: (2017)

From expert recommendations to multidisciplinary team decisions: a way to set out the novel perioperative options for patients with non-small-cell lung cancer
por: Banna, Giuseppe Luigi, et al.
Publicado: (2022)

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
por: Landi, Lorenza, et al.
Publicado: (2019)

Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
por: Sa, Huanlan, et al.
Publicado: (2019)

Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023)

COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
por: Leonetti, Alessandro, et al.
Publicado: (2020)

MET and Small-Cell Lung Cancer
por: Gelsomino, Francesco, et al.
Publicado: (2014)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer
por: Peng, Yurong, et al.
Publicado: (2023)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

Expert opinions on immunotherapy for patients with colorectal cancer
por: Wang, Feng, et al.
Publicado: (2020)

Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with Gefitinib
por: Gozzi, Fabrizio, et al.
Publicado: (2021)

Immunotherapy in non‐small cell lung cancer: The past, the present, and the future
por: Lu, Meng, et al.
Publicado: (2019)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Editorial: Bench Research Behind Lung Cancer Surgery
por: Bertolaccini, Luca, et al.
Publicado: (2022)

Paying Another Tribute to the COVID-19 Pandemic: The Decrease of Early Lung Cancers
por: Bertolaccini, Luca, et al.
Publicado: (2021)

Expert consensus on COVID-19 vaccination in children
por: Zheng, Yue-Jie, et al.
Publicado: (2021)

Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer
por: Zhang, Shirong, et al.
Publicado: (2022)

Asia expert consensus on segmentectomy in non–small cell lung cancer: A modified Delphi study
por: Liu, Lunxu, et al.
Publicado: (2023)

Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China
por: Pu, Xingxiang, et al.
Publicado: (2023)

Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence
por: Cao, Christopher, et al.
Publicado: (2020)

Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint
por: Faltermeier, Claire M., et al.
Publicado: (2021)

The importance of being solid for a ground glass opacity of the lung
por: Bertolaccini, Luca, et al.
Publicado: (2021)

Next-Generation Lung Cancer Surgery: A Brief Trip into the Future of the Research
por: Uslenghi, Clarissa, et al.
Publicado: (2023)

Chinese expert consensus statement on issues related to small specimen sampling of lung cancer
Publicado: (2017)

An overview of Chinese multidisciplinary expert consensus on perioperative brain health in elderly patients
por: Li, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7c6k2j87sd558nv0okcgo9dqn